Trial Information
A phase 1/2 study of IDE196 in patients with solid tumors harboring GNAQ/11 mutations or PRKC fusions
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
A phase 1/2 study of IDE196 in patients with solid tumors harboring GNAQ/11 mutations or PRKC fusions
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
View our locations on map!